natgillin/translations-raw huggingface dataset:
Treatment of diabetic peripheral neuropathic pain.
Zdravljenje bolečine zaradi diabetične periferne nevropatije.
Treatment of diarrhoea at the first signs is important (see section 4)
Pomembno je, da jo zdravite takoj po prvih znakih (glejte poglavje 4);
Treatment of DVT and PE, and prevention of recurrent DVT and PE in adults (DVT/PE)
Zdravljenje globoke venske tromboze (GVT) in pljučne embolije (PE) ter preprečevanje ponovitve GVT in PE pri odraslih (GVT/PE)
Treatment of DVT, PE and prevention of recurrence
Zdravljenje GVT, PE in preprečevanje ponovne GVT in PE
Treatment of DVT, PE and prevention of recurrent DVT and PE
Zdravljenje GVT, PE in preprečevanje ponovne GVT in PE
Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE
Zdravljenje GVT, zdravljenje PE ter preprečevanje ponovne GVT in PE
Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE (VTE)
Zdravljenje GVT, zdravljenje PE ter preprečevanje ponovljene GVT in PE (VTE)
Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE (VTE)
Zdravljenje GVT, zdravljenje PE ter preprečevanje ponovne GVT in PE (VTE)
Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE (VTEt)
Zdravljenje GVT, zdravljenje PE in preprečevanje ponovne GVT ter PE (VTEt)
Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE (VTEt)
Zdravljenje GVT, zdravljenje PE ter preprečevanje ponovne GVT in PE (VTEt)
Treatment of DVT, treatment of PE and the prevention of recurrent DVT and PE (VTE)
Zdravljenje GVT, zdravljenje PE in preprečevanje recidivnih GVT in PE (VTE)
Treatment of ear mites (cats)
Zatiranje ušesnih garij (mačke)
Treatment of ear mites (dogs)
Zatiranje ušesnih garij (psi)
Treatment of ear mites (Otodectes cynotis).
Zatiranje ušesnih garij (Otodectes cynotis).
Treatment of essential hypertension in adults: Add on therapy
Zdravljenje esencialne hipertenzije pri odraslih: Dodatno zdravljenje
Treatment of essential hypertension.
Zdravljenje esencialne hipertenzije
Treatment of essential hypertension:
Zdravljenje esencialne hipertenzije
Treatment of flea infestation in dogs (Ctenocephalides felis and C. canis) for at least 5 weeks.
Zdravljenje infestacije z bolhami pri psih (Ctenocephalides felis and C. canis) vsaj 5tednov.
Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs for 5 weeks.
Zdravljenje infestacije z bolhami pri psih (Ctenocephalides felis and C. canis) traja do 5tednov.
Treatment of flea infestations (Ctenocephalides felis and C.canis) in dogs.
Zdravljenje infestacije z bolhami (Ctenocephalides felis and C. canis) pri psih.
Treatment of flea infestations (Ctenocephalides felis); the product has persistent insecticidal efficacy for up to 4 weeks against Ctenocephalides felis.
Zdravljenje infestacije z bolhami (Ctenocephalides felis); zdravilo deluje insekticidno do 4 tedne na
Treatment of fluconazole-resistant serious invasive Candida infections (including C. krusei).
zdravljenje hudih, invazivnih, proti flukonazolu odpornih okužb s Candido (vključno s C. krusei)
Treatment of gastro-intestinal nematodes in chickens infected with:
Zdravljenje gastrointestinalnih nematodov pri piščancih, ki so okuženi z:
Treatment of gouty arthritis attacks as measured by pain intensity (VAS) at 72 h
zdravljenje napadov uričnega artritisa: ocena intenzivnosti bolečine (na lestvici VAS) po 72 urah
Treatment of growth retardation in pre-pubertal children with chronic renal insufficiency.
Zdravljenje zastoja v rasti pri otrocih pred puberteto s kronično ledvično insuficienco.
Treatment of high blood phosphorus levels is usually required for a long period of time.
Zdravljenje visokih ravni fosforja v krvi običajno traja dolgo.
Treatment of high blood phosphorus levels usually requires long-term treatment.
Zdravljenje visokih ravni fosforja v krvi je običajno dolgotrajno.
Treatment of HIV-1 infection
Zdravljenje okužbe s HIV–1
Treatment of HIV-1 infection:
Zdravljenje okužbe z virusom HIV–1:
Treatment of HIV-1 infection: In an open-label randomised clinical study (GS-01-934), antiretroviral-naïve HIV-1 infected patients received either a once daily regimen of emtricitabine, tenofovir disoproxil fumarate and efavirenz (n=255) or a fixed combination of lamivudine and zidovudineadministered twice daily and efavirenz once daily (n=254).
Zdravljenje okužbe z virusom HIV–1: V odprti, randomizirani klinični študiji (GS-01-934) so bolniki z okužbo HIV-1, ki še niso bili zdravljeni s protiretrovirusnimi zdravili, prejemali režim zdravljenja z emtricitabinom, dizoproksiltenofovirijevim fumaratom in efavirenzom (n=255) enkrat na dan ali fiksno kombinacijo lamivudina in zidovudina dvakrat na dan in efavirenz enkrat na dan (n=254).
Treatment of hookworm infections (cats)
Zdravljenje infestacij z Ancylostoma tubaeformae (mačke)
Treatment of hookworm infections (cats)
Zdravljenje infestacij z nematodi Ancylostoma tubaeformae (mačke)
treatment of infections
zdravljenje okužb
Treatment of infections due to Gram-negative bacteria such as E. coli.
Zdravljenje infekcij, ki jih povzroča gramnegativne bakterija kot je E.coli.
Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis sensitive to tulathromycin.
Zdravljenje infekcioznega govejega keratokonjuktivitisa (IBK), povzročenega z Moraxella bovis občutljivo na Tulatromicin.
Treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum and Ancylostoma braziliense) and whipworm (Trichuris vulpis).
Zdravljenje infestacij z odraslimi gastrointestinalnimi nematodi naslednjih vrst: valjasti črvi (Toxocara canis in Toxascaris leonina), kavljasti črvi ( Ancylosotma caninum in Ancylostoma brazilienze), in bičeglavci (Trichuris vulpis).
Treatment of infestations with adult gastrointestinal worms of the following species: roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum and Ancylostoma braziliense) and whipworm (Trichuris vulpis).
Zdravljenje infestacij z odraslimi gastrointestinalnimi glistami naslednjih vrst: valjasti črvi (Toxocara canis in Toxascaris leonina), kavljasti črvi ( Ancylosotma caninum, in Ancylostoma brazilienze), in Trichuris vulpis.
Treatment of infestations with feline lungworm (L3 larvae, L4 larvae and adults of
Zdravljenje infestacij z mačjimi pljučnimi črvi (L3 ličinke, L4 ličinke in odrasli
Treatment of infestations with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, L4 larvae and adults of Ancylostoma tubaeforme, and adult forms of Toxascaris leonina and Ancylostoma brazilienze).
Zdravljenje infestacij z gastrointestinalnimi nematodi (L3, L4 ličinke in odrasli paraziti Toxocara cati, L4 ličinke in odrasli paraziti Ancylosotma tubaeforme, in odrasle oblike Toxascaris leonina in Ancylostoma brazilienze).
Treatment of infestations with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, L4 larvae and adults of Ancylostoma tubaeforme, and adult forms of Toxascaris leonina and Ancylostoma brazilienze).
Zdravljenje infestacij z gastrointestinalnimi nematodi (L3, L4 ličinke, in odrasli paraziti Toxocara cati, L4 ličinke in odrasli paraziti Ancylosotma tubaeforme, in odrasle oblike Toxascaris leonina in Ancylostoma brazilienze).
Treatment of infestations with tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis).
Zdravljenje infestacij s trakuljami (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis).
Treatment of infestations with vesical worms (Capillaria plica).
Zdravljenje infestacij z vezikalnimi črvi (Capillaria plica).
Treatment of influenza in children: In a study of otherwise healthy children (65 % influenza-positive) aged 1 to 12 years (mean age 5.3 years) who had fever (≥ 37.8 °C) plus either cough or coryza, 67 % of influenza-positive patients were infected with influenza A and 33 % with influenza B. Oseltamivir treatment, started within 48 hours of onset of symptoms, significantly reduced the time to freedom from illness (defined as the simultaneous return to normal health and activity and alleviation of fever, cough and coryza) by 1.5 days (95 % CI 0.6 – 2.2 days; p < 0.0001) compared to placebo.
Zdravljenje gripe pri otrocih: v študiji sicer zdravih otrok (65 % okuženih z gripo), starih od 1 do 12 let (srednja starost 5,3 let), ki so imeli zvišano telesno temperaturo (≥ 37,8 °C) ter kašelj ali nahod, je bilo 67 % bolnikov okuženih z virusom influence tipa A, 33 % pa z virusom influence tipa B. Zdravljenje z oseltamivirjem, ki so ga začeli v 48 urah po nastopu simptomov, je pomembno skrajšalo čas do obdobja brez bolezni (definirano kot sočasna vrnitev normalnega zdravja in aktivnosti ter znižanje zvišane telesne temperature, ublažitev kašlja in nahoda) za 1,5 dni (95-% interval zaupanja 0,6 – 2,2 dni; p < 0,0001) v primerjavi s placebom.
Treatment of influenza in children: In a study of otherwise healthy children (65 % influenza-positive) aged 1 to 12 years (mean age 5.3 years) who had fever ( 37.8 °C) plus either cough or coryza, 67 % of influenza-positive patients were infected with influenza A and 33 % with influenza B. Oseltamivir treatment, started within 48 hours of onset of symptoms, significantly reduced the time to freedom from illness (defined as the simultaneous return to normal health and activity and alleviation of fever, cough and coryza) by 1.5 days (95 % CI 0.6 – 2.2 days; p < 0.0001) compared to placebo.
Zdravljenje gripe pri otrocih: v študiji sicer zdravih otrok (65 % okuženih z gripo), starih od 1 do 12 let (srednja starost 5,3 let), ki so imeli zvišano telesno temperaturo ( 37,8 °C) ter kašelj ali nahod, je bilo 67 % bolnikov okuženih z virusom influence tipa A, 33 % pa z virusom influence tipa B. Zdravljenje z oseltamivirjem, ki so ga začeli v 48 urah po nastopu simptomov, je pomembno skrajšalo čas do obdobja brez bolezni (definirano kot sočasna vrnitev normalnega zdravja in aktivnosti ter znižanje zvišane telesne temperature, ublažitev kašlja in nahoda) za 1,5 dni (95-% interval zaupanja 0,6 – 2,2 dni; p < 0,0001) v primerjavi s placebom.
Treatment of influenza in children: In a study of otherwise healthy children (65 % influenza-positive) aged 1 to 12 years (mean age 5.3 years) who had fever ( 37.8 °C) plus either cough or coryza, 67 % of influenza-positive patients were infected with influenza A and 33 % with influenza B. Oseltamivir treatment, started within 48 hours of onset of symptoms, significantly reduced the time to freedom from illness (defined as the simultaneous return to normal health and activity and alleviation of fever, cough and coryza) by 1.5 days (95 % CI 0.6 – 2.2 days; p < 0.0001) compared to placebo.
Zdravljenje gripe pri otrocih: v študiji sicer zdravih otrok (65 % okuženih z gripo), starih od 1 do 12 let (srednja starost 5,3 let), ki so imeli zvišano telesno temperaturo ( 37,8 °C) ter kašelj ali nahod, je bilo 67 % bolnikov okuženih z virusom influence tipa A, 33 % pa z virusom influence tipa B. Zdravljenje z oseltamivirjem, ki so ga začeli v 48 urah po nastopu simptomov, je pomembno skrajšalo čas do obdobja brez bolezni (definirano kot sočasna vrnitev normalnega zdravja in aktivnosti ter znižanje zvišane telesne temperature, ublažitev kašlja in nahoda) za 1,5 dni (95-% interval zaupanja 0,6–2,2 dni; p < 0,0001) v primerjavi s placebom.
Treatment of influenza in high risk populations: The median duration of influenza illness in older subjects (≥ 65 years) and in subjects with chronic cardiac and/or respiratory disease receiving oseltamivir 75 mg twice daily for 5 days was not reduced significantly.
Zdravljenje gripe pri bolnikih z visokim tveganjem: mediana časa trajanja gripe pri starejših bolnikih (starih 65 let ali več) in pri bolnikih s kronično boleznijo srca ali dihal ali obojim, ki so prejemali odmerek 75 mg oseltamivirja dvakrat na dan 5 dni, ni bila pomembno znižana.
Treatment of influenza in pregnant women: No controlled clinical studies have been conducted on the use of oseltamivir in pregnant women, however, there is evidence from post-marketing and retrospective observational studies showing benefit of the current dosing regimen in this patient population in terms of lower morbidity/mortality.
Zdravljenje gripe pri nosečnicah: Kontroliranih kliničnih študij o uporabi Ebilfumin pri nosečnicah niso izvedli, vendar so iz obdobja po prihodu zdravila na trg in opazovalnih študij na voljo dokazi o koristi veljavnega režima odmerjanja pri tej populaciji bolnic v smislu manjše obolevnosti/smrtnosti/.
Treatment of influenza in pregnant women: No controlled clinical studies have been conducted on the use of oseltamivir in pregnant women, however, there is evidence from post-marketing and retrospective observational studies showing benefit of the current dosing regimen in this patient population in terms of lower morbidity/mortality.
Zdravljenje gripe pri nosečnicah: Kontroliranih kliničnih študij o uporabi oseltamivirja pri nosečnicah niso izvedli, vendar so iz obdobja po prihodu zdravila na trg in opazovalnih študij na voljo dokazi o koristi veljavnega režima odmerjanja pri tej populaciji bolnic v smislu manjše obolevnosti/smrtnosti/.
Treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin B, lipid formulations of amphotericin B and/or itraconazole.
Zdravljenje invazivne aspergiloze pri odraslih ali pediatričnih bolnikih, ki so nedovzetni za zdravljenje z amfotericinom B, lipidnimi pripravki amfotericina B in/ali itrakonazolom ali teh zdravil ne prenašajo.
Treatment of invasive aspergillosis.
zdravljenje invazivne aspergiloze
Treatment of invasive candidiasis in adult or paediatric patients.
Zdravljenje invazivne kandidiaze pri odraslih ali pediatričnih bolnikih.
Treatment of invasive candidiasis.
Zdravljenje invazivne kandidoze.
Treatment of KS lesions in close proximity to other skin disorders.
Zdravljenje KS lezij, ki se pojavijo v neposredni bližini drugih bolezni kože.
Treatment of major depressive episodes.
Zdravljenje velikih depresivnih epizod.
treatment of mantle cell lymphoma.
zdravljenje limfoma plaščnih celic.
Treatment of moderate to severe atopic dermatitis in children (2 years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids.
Zdravljenje zmernega do hudega atopičnega dermatitisa pri otrocih (starih 2 leti ali več), ki se na konvencionalne terapije, kot so lokalni kortikosteroidi, ne odzovejo ustrezno.
Treatment of moderate to severe atopic dermatitis in children who failed to respond adequately to conventional therapies such as topical corticosteroids.
Zdravljenje zmernega do hudega atopičnega dermatitisa pri otrocih, ki se na konvencionalne terapije, kot so lokalni kortikosteroidi, ne odzovejo ustrezno.
treatment of multiple myeloma;
zdravljenje multiplega mieloma
treatment of myelodysplastic syndromes;
zdravljenje mielodisplastičnih sindromov
Treatment of nausea or vomiting with such medicines together with bosulif may result in a greater risk of dangerous heart arrhythmias.
Zdravljenje slabosti ali bruhanja s temi zdravili skupaj z zdravilom Bosulif lahko povzroči večje tveganje za pojav nevarnih srčnih aritmij.
Treatment of non-resectable Patnaik grade II (intermediate grade) or III (high grade), recurrent, cutaneous mast cell tumours in dogs.
Zdravljenje neoperabilnega Patnaika stopnje II (srednja stopnja) ali stopnje III (visoka stopnja) ponavljajočega se kožnega mastocitoma pri psih.
Treatment of notoedric mange (Notoedres cati)
Zdravljenje garjavosti, ki jo povroča pršica vrste Notoedres cati
Treatment of notoedric mange (Notoedres cati)
Zdravljenje garjavosti, ki jo povzročajo pršice iz rodu Notoedres cati
Treatment of notoedric mange (Notoedres cati).
Zdravljenje garjavosti notoedric (Notoedres cati).
Treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate.
Zdravljenje kandidoze požiralnika pri bolnikih, za katere je intravensko zdravljenje primerno.
Treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 months since the last menses) for whom treatment with progestin-containing therapy is not appropriate.
Zdravljenje simptomov pomanjkanja estrogena pri ženskah v postmenopavzi z maternico (vsaj 12 mesecev od zadnje menstruacije), pri katerih zdravljenje s progestini ni primerno.
Treatment of osteoporosis in men
Zdravljenje osteoporoze pri moških
Treatment of osteoporosis in post-menopausal women
Zdravljenje osteoporoze
Treatment of osteoporosis in post-menopausal women
Zdravljenje osteoporoze pri postmenopavzalnih ženskah
Treatment of osteoporosis in postmenopausal women
Zdravljenje osteoporoze pri ženskah po menopavzi
Treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1).
Zdravljenje osteoporoze pri ženskah po menopavzi, ki imajo povečano tveganje za zlome (glejte poglavje 5.1).
Treatment of osteoporosis with combination and sequential therapy
Zdravljenje osteoporoze s kombinacijskim zdravljenjem in zaporednim zdravljenjem
Treatment of overdosage of Tandemact primarily consists of preventing absorption of glimepiride by inducing vomiting and then drinking water or lemonade with activated charcoal (adsorbent) and sodium-sulphate (laxative).
V primeru prevelikega odmerjanja zdravila Tandemact je potrebno preprečiti absorpcijo glimepirida s spodbujanjem bruhanja, čemur naj sledi pitje vode ali limonade z aktivnim ogljem (adsorbent) in natrijevim sulfatom (odvajalo).
Treatment of overdose should consist of general supportive measures including keeping the patient in a supine position, careful assessment of patient vital signs, blood pressure and ECG.
Zdravljenje prevelikega odmerjanja mora obsegati splošne podporne ukrepe, vključno s tem, da bolnik leži, in natančno oceno bolnikovih vitalnih znakov, krvnega tlaka in EKG.
Treatment of overdose should consist of general supportive measures, including monitoring of vital signs and observation of the patient’s clinical status.
Zdravljenje mora zajemati splošne podporne ukrepe, med njimi spremljanje življenjskih znakov in bolnikovega kliničnega stanja.
Treatment of overdose should follow standard medical practice.
Pri zdravljenju prevelikega odmerjanja je treba upoštevati standardno medicinsko prakso.
Treatment of overdose with daclatasvir should consist of general supportive measures, including monitoring of vital signs, and observation of the patient’s clinical status.
Zdravljenje prevelikega odmerjanja daklatasvirja mora obsegati splošne podporne ukrepe, vključno s spremljanjem vitalnih znakov in opazovanjem kliničnega stanja bolnika.
Treatment of overdose with efavirenz should consist of general supportive measures, including monitoring of vital signs and observation of the patient’s clinical status.
Zdravljenje prevelikega odmerjanja z efavirenzem naj vključuje splošne podporne ukrepe, vključno s spremljanjem življenjskih znakov in opazovanjem bolnikovega kliničnega stanja.
Treatment of overdose with saquinavir should consist of general supportive measures, including monitoring of vital signs and ECG, and observations of the patient’s clinical status.
Zdravljenje prevelikega odmerjanja s sakvinavirjem naj bi sestavljali splošni podporni ukrepi, kot so spremljanje vitalnih znakov in EKG ter opazovanje bolnikovega kliničnega statusa.
Treatment of overdose with Victrelis should consist of general supportive measures, including monitoring of vital signs, and observation of the patient’s clinical status.
Zdravljenje prevelikega odmerjanja zdravila Victrelis mora obsegati splošne podporne ukrepe, vključno z nadziranjem vitalnih znakov in opazovanjem bolnikovega kliničnega stanja.
Treatment of paediatric patients with chemotherapy-induced anaemia
Zdravljenje pediatričnih bolnikov z anemijo, ki je posledica kemoterapije
Treatment of Paget’s disease of the bone in adults.
Zdravljenje Pagetove bolezni kosti pri odraslih.
Treatment of Parkinson’s disease
Zdravljenje Parkinsonove bolezni
Treatment of patients with chemotherapy-induced anaemia
Zdravljenje odraslih bolnikov z anemijo zaradi kemoterapije
Treatment of patients with hairy cell leukaemia.
Zdravljenje bolnikov z dlakastocelično levkemijo.
Treatment of patients with moderate (Child Pugh B) and severe (Child Pugh C) hepatic impairment with Vargatef is not recommended (see sections 4.4 and 5.2).
Zdravljenja bolnikov z zmerno (Child Pugh B) in hudo (Child Pugh C) jetrno okvaro z zdravilom Vargatef ne priporoča (glejte poglavje 5.2).
Treatment of patients with moderate to severe Alzheimer’s disease.
Zdravljenje bolnikov z zmerno do hudo Alzheimerjevo boleznijo.
Treatment of patients with pre-existing severe hepatic impairment (Child-Pugh class C) with Zinbryta is not appropriate.
Zdravljenje bolnikov z obstoječo hudo okvaro jeter (razred C po Child-Pughu) z zdravilom Zinbryta ni primerno.
Treatment of Peyronie’s plaques that involve the penile urethra due to potential risk to this structure.
Zdravljenje Peyroniejevih plakov, ki zajemajo sečnico penisa, zaradi potencialnega tveganja za to strukturo.
Treatment of Physician’s Choice
Zdravljenje po izbiri zdravnika (PIZ)
Treatment of piglets with Rheumocam before castration reduces post operative pain.
Zdravljenje pujskov z zdravilom Rheumocam pred kastracijo blaži postoperativno bolečino.
Treatment of platinum-resistant recurrent disease: Avastin is administered in combination with one of the following agents – paclitaxel, topotecan (given weekly) or pegylated liposomal doxorubicin.
Zdravljenje ponovitve bolezni, ki je rezistentna na platino: zdravilo Avastin dajemo v kombinaciji z enim od naslednjih zdravil: paklitakselom, topotekanom (s tedenskim odmerjanjem) ali pegiliranim liposomalnim doksorubicinom.
Treatment of porcine proliferative enteropathy (ileitis) caused by Lawsonia intracellularis in herds where there is a diagnosis based on clinical history, post-mortem findings and clinical pathology results.
Zdravljenje prašičje proliferativne enteropatije (ileitis), ki jo povzroča Lawsonia intracellularis v čredah, kjer je bila diagnoza osnovana na klinični zgodovini, ugotovitvah post mortem in rezultatih klinične patologije.
Treatment of porcine proliferative enteropathy (ileitis) caused by Lawsonia intracellularis in herds where there is a diagnosis based on clinical history, post-mortem findings and clinical pathology results.
Zdravljenje prašičje proliferativne enteropatije (ileitis), ki jo povzroča Lawsonia intracellularis v čredah, kjer je bila diagnoza osnovana na klinični zgodovini, ugotovitvah post mortem in ugotovitvah klinične patologije.
Treatment of porcine proliferative enteropathy caused by Lawsonia intracellularis in herds where there is a diagnosis based on clinical history, post-mortem findings and clinical pathology results.
Zdravljenje prašičje proliferativne enteropatije, ki jo povzroča Lawsonia intracellularis v čredah, kjer je diagnoza postavljena na podlagi klinične anamneze, ugotovitev avtopsij in rezultatov klinične patologije.
Treatment of porcine proliferative enteropathy caused by Lawsonia intracellularis.
Zdravljenje prašičje proliferativne enteropatije, ki jo povzroča Lawsonia intracellularis.
Treatment of post-operative pain following coronary artery bypass graft (CABG) surgery (see sections 4.8 and 5.1).
zdravljenje pooperacijske bolečine CABG (operativna vstavitev presadka koronarnega obvoda) (glejte poglavji 4.8 in 5.1),
Treatment of postmenopausal osteoporosis:
Zdravljenje bolnic s pomenopavzno osteoporozo:
Treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation.
Zdravljenje otrok pred puberteto, ki zaradi kronične insuficience ledvic zaostajajo v rasti, do presaditve ledvice.
Treatment of pruritus associated with allergic dermatitis in dogs.
Zdravljenje pruritusa v povezavi z atopičnim dermatitisom pri psih.
treatment of pulmonary
pljučne arterijske
Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO functional class III.
Zdravljenje pljučne arterijske hipertenzije (PAH-Pulmonary Arterial Hypertension), da bi se izboljšala fizična zmogljivost in simptomi pri bolnikih s III. funkcijskim razredom po SZO.